- Home
- ATOS vs FCEL Comparison
ATOS vs FCEL Comparison
Compare ATOS & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- FCEL
- Stock Information
- Founded
- ATOS 2009
- FCEL 1969
- Country
- ATOS United States
- FCEL United States
- Employees
- ATOS N/A
- FCEL N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- FCEL Industrial Machinery/Components
- Sector
- ATOS Health Care
- FCEL Energy
- Exchange
- ATOS Nasdaq
- FCEL Nasdaq
- Market Cap
- ATOS 107.2M
- FCEL 116.0M
- IPO Year
- ATOS 2012
- FCEL 1992
- Fundamental
- Price
- ATOS $0.94
- FCEL $5.39
- Analyst Decision
- ATOS Strong Buy
- FCEL Hold
- Analyst Count
- ATOS 3
- FCEL 6
- Target Price
- ATOS $6.17
- FCEL $14.11
- AVG Volume (30 Days)
- ATOS 1.5M
- FCEL 2.1M
- Earning Date
- ATOS 08-11-2025
- FCEL 09-04-2025
- Dividend Yield
- ATOS N/A
- FCEL N/A
- EPS Growth
- ATOS N/A
- FCEL N/A
- EPS
- ATOS N/A
- FCEL N/A
- Revenue
- ATOS N/A
- FCEL $129,424,000.00
- Revenue This Year
- ATOS N/A
- FCEL $40.32
- Revenue Next Year
- ATOS N/A
- FCEL $36.17
- P/E Ratio
- ATOS N/A
- FCEL N/A
- Revenue Growth
- ATOS N/A
- FCEL 48.62
- 52 Week Low
- ATOS $0.55
- FCEL $3.58
- 52 Week High
- ATOS $1.66
- FCEL $21.60
- Technical
- Relative Strength Index (RSI)
- ATOS 58.44
- FCEL 47.57
- Support Level
- ATOS $0.81
- FCEL $5.11
- Resistance Level
- ATOS $0.88
- FCEL $6.32
- Average True Range (ATR)
- ATOS 0.05
- FCEL 0.39
- MACD
- ATOS 0.01
- FCEL -0.07
- Stochastic Oscillator
- ATOS 84.07
- FCEL 23.31
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company operates in USA, South Korea, Europe and Canada. Majority of revenue is from USA and South Korea.